Abstract 1812: Adaptive and acquired resistance to GNAQ/11 inhibition in uveal melanoma

作者
Jiafang Ma,Boris C. Bastian,Xu Chen
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:80 (16_Supplement): 1812-1812
标识
DOI:10.1158/1538-7445.am2020-1812
摘要

Abstract Uveal Melanoma (UM) is a highly lethal cancer with 50% of patients developing lethal metastatic disease, primarily the liver, with currently no effective treatment options. UM is driven by mutations constitutively activating the Gαq pathway, about 90% affecting the heterotrimeric G-protein alpha subunits GNAQ or GNA11 and less commonly (<10%) CYSLTR2 (a GNAQ/11 coupled receptor) or PLCB4 (a direct effector of Gαq). Directly targeting GNAQ/11 therefore could be of therapeutic relevance for the majority of UMs. Here we found that YM-254890, a cyclic depsipeptide, inhibited downstream signaling induced by GNAQQ209L and GNA11Q209L, but not GNA14Q205L, GNA15Q212L and GNASQ227L in 293T cells, confirming that it is a GNAQ/11-specific inhibitor. We systematically examined its activity against other recurring mutations in the Gαq pathway (GNAQ: Q209P, G48V, T175R, R183Q, F228L; GNA11:E191G, R183C, E234K; CYSLTR2: L129Q; PLCB4: D630Y). In 293T cells GNAQQ209P, GNAQR183Q, CYSLTR2L129Q and PLCB4D630Y activated downstream signaling whereas other Gαq mutants did not. YM-254890 inhibited the downstream signaling induced by GNAQQ209P, GNAQR183Q and CYSLTR2L129Q whereas it remained expectedly ineffective against PLCB4D630Y. Furthermore, we found that YM-254890 selectively inhibited Gαq signaling and cell proliferation in a panel of UM cell lines with GNAQ/11 mutations but had no effect on Gαq wild type melanoma cells. In vivo, YM-254890 slowed the growth of liver metastases in a xenograft model of GNAQ mutant UM cells but did not induce tumor shrinkage. Analysis of the tumor lysates revealed that inhibition of Gαq pathway signaling was incomplete. RNAseq analysis of 10 UM cell lines with various GNAQ/11 mutations exposed to YM-254890 revealed that GNAQ/11 inhibition led to significant upregulation of endothelin ET(B) receptor (EDNRB) compared to control treatment. EDNRB is a GNAQ/11 coupled receptor, and western blot confirmed that EDNRB protein level was significantly upregulated when mutant GNAQ/11 was inhibited with either YM-254890 or siRNA. The critical role of endothelin signaling in mediating adaptive resistance to Gαq inhibition was confirmed by demonstrating (1) expression of the EDNRB ligand endothelin 1 in liver metastases of the xenograft model; (2) pharmacological or genetic inhibition of EDNRB was able to break resistance. We also found that the therapeutic efficacy of YM-254890 can be subverted by acquiring additional mutations in the pathway. Upon chronic growth suppression of a GNA11Q209L mutant UM cell line a resistant clone emerged that was demonstrated to harbor a novel GNA11F75Y mutation, affecting the YM-254890 binding site. Concordantly, an engineered GNA11 with the two mutations in cis was resistant to the compound. Our data suggest that targeting mutant GNAQ/11 is promising but will require combinatorial targeting of EDNR signaling and possibly other pathways to reach maximal clinical efficacy. Citation Format: Jiafang Ma, Boris C. Bastian, Xu Chen. Adaptive and acquired resistance to GNAQ/11 inhibition in uveal melanoma [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 1812.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小王发布了新的文献求助10
刚刚
生动的乐曲完成签到,获得积分10
刚刚
1秒前
生动的访琴完成签到,获得积分10
1秒前
r12r1完成签到,获得积分10
2秒前
姜姜完成签到,获得积分10
2秒前
throb发布了新的文献求助10
2秒前
零零1完成签到 ,获得积分10
3秒前
碎觉觉发布了新的文献求助10
4秒前
5秒前
5秒前
5秒前
Nuyoah完成签到 ,获得积分10
6秒前
转复窦律完成签到,获得积分10
6秒前
粗犷的翎完成签到,获得积分10
6秒前
可爱安荷发布了新的文献求助10
7秒前
9秒前
cyy完成签到,获得积分10
9秒前
9秒前
啊汪~发布了新的文献求助10
11秒前
12秒前
throb完成签到,获得积分10
12秒前
大模型的应助被七听采纳,获得10
12秒前
方圆完成签到 ,获得积分10
14秒前
14秒前
遇见完成签到,获得积分20
15秒前
15秒前
2275523154完成签到,获得积分10
15秒前
千里清秋完成签到,获得积分10
15秒前
quan完成签到,获得积分10
15秒前
美宁完成签到,获得积分10
17秒前
顺利的妖妖完成签到 ,获得积分10
18秒前
再睡十分钟完成签到 ,获得积分10
18秒前
penicillin完成签到 ,获得积分10
18秒前
辛勤以柳发布了新的文献求助10
20秒前
敏感的傲云完成签到,获得积分10
20秒前
20秒前
xiahaijun发布了新的文献求助10
21秒前
21秒前
情怀的应助被七听采纳,获得10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190478
求助须知:如何正确求助?哪些是违规求助? 9577686
关于积分的说明 21853808
捐赠科研通 7789496
什么是DOI,文献DOI怎么找? 3436407
关于科研通互助平台的介绍 2560235
邀请新用户注册赠送积分活动 2483054